Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 6Gastrointestinal 4Other solid neoplasm 3Genitourinary 3Other 2Dermatologic 2Other neoplasm 1Other hematologic neoplasm 1Gynecologic 1

Conditions

Melanoma 2Spondylitis, Ankylosing 1Psoriasis 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1

Interventions

pembrolizumab 24Specimen Handling 21Nivolumab 20Magnetic Resonance Spectroscopy 16Ipilimumab 12Biopsy 9Cyclophosphamide 5CTLA-4 Antigen 5relatlimab 4Opdualag 4HhAntag691 4trametinib 3fludarabine 3dabrafenib 3cemiplimab 3binimetinib 3avelumab 3aldesleukin 3Surgical Procedures, Operative 3Radiosurgery 3Paclitaxel 3Cisplatin 3Carboplatin 3talimogene laherparepvec 2omipalisib 2capivasertib 2atezolizumab 2X-Rays 2Taxes 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Methods × Dermatologic × 30 days × Clear all
NCT04611568 2026-05-22

War on Melanomaâ„¢ Public Health & Education Campaign

OHSU Knight Cancer Institute

Phase NA Active not recruiting
75,000 enrolled
Dermatologic

Melanoma

NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡